Adar Poonawalla-backed pharmacy chain Wellness Forever files for IPO

Plans to raise Rs 1,500-1,600 cr; This is the second pharmacy chain to file for IPO after Hyderabad-based MedPlus, which filed its DRHP with Sebi in August

Adar Poonawalla, CEO, Serum Institute
The omni-channel retail pharmacy chain has already filed a draft red herring prospectus with the market regulator.
Sohini Das Mumbai
2 min read Last Updated : Oct 02 2021 | 12:52 AM IST
Adar Poonawalla backed pharmacy chain Wellness Forever Medicare is planning to go for an initial public offering (IPO) to raise between Rs 1,500-1,600 crore.

The omni-channel retail pharmacy chain has already filed a draft red herring prospectus with the market regulator. The pharmacy chain’s revenue for the financial year ended March 31, 2021, grew to Rs 924.02 crore, from Rs 863.25 crore in the previous fiscal year.

This will be the second pharmacy chain to file for an IPO after Hyderabad-based MedPlus, which filed its DRHP with Sebi in August.

The IPO consists of a fresh issue of equity shares aggregating to Rs 400 crore and an offer for sale up to 1.60 crore equity shares, according to DRHP.

The company proposes to utilise net proceeds from the fresh issue to the tune of Rs 70.20 crore for funding capital expenditure for setting up new outlets, repayment or prepayment in part or full of certain borrowings amounting to Rs 100 crore, funding its working capital requirements to the extent of Rs 121.90 crore besides general corporate purposes

The Mumbai-based brand Wellness Forever founded by Ashraf Biran, Gulshan Bakhtiani and Mohan Chavan in 2008, has 236 stores across 23 cities in Maharashtra, Goa, Karnataka.

As of June 30, 2021, it serves a registered customer base of 6.7 million customers. It now intends to deepen its penetration in tier 2 and 3 markets besides participating actively in the growing pharmacy e-commerce segment which is expected to grow at a 45 percent CAGR.

IIFL Securities Limited, Ambit Private Limited, DAM Capital Advisors Limited, and HDFC Bank Limited are book running lead managers to the issue.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :IPOSEBIpharmacy

Next Story